-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Department of Public Health England said in a statement on Monday (December 14) that as of December 13, 1,108 cases of COVID-19 with the new variant had been identified, mainly in southern and eastern England
Sharon Peacock, head of the British COVID-19 Genome Consortium (COG-UK), said: “At present, we still have very little evidence for this variant
The team first discovered a new variant of the virus in late September and began to track its spread, but the sudden epidemic of the new variant still surprised experts
Nick Loman, professor of microbial genomics at the University of Birmingham and one of the founders of COG-UK, said: “This variant strain is rising rapidly
Scientists detected 17 mutations in this variant.
Jeremy Farrar, director of the Wellcome Foundation's Biomedical Research Foundation, issued a statement on Monday, saying that this development "may be serious" and the impact on the spread of the virus and the efficacy of the vaccine is unclear
However, British COG scientists emphasized that mutations are very common, with various strains appearing and disappearing quickly
Even if the virus mutates, experts believe that it is unlikely to mutate in a way that makes the vaccine ineffective
